Ginkgo Bioworks Holdings

DNA54

$7.31arrow_drop_down15.00%-$1.29

DNA54

$7.31

arrow_drop_down15.00%-$1.29

Performance History

Key Stats
Open	$8.67
Prev. Close	$8.49
EPS	-18.00
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	8.34	8.94
52 Week Range	5.26	75.20

Ratios







EPS	-18.00

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Ginkgo Bioworks Holdings (DNA)

Ginkgo Bioworks Holdings, Inc., also known as DNA, is a biotechnology company that focuses on leveraging the power of synthetic biology to design and manufacture organisms for a wide range of applications. The company was founded in 2008 by a group of MIT scientists and has since grown into one of the leading players in the field. DNA's mission is to make biology easier to engineer, and they achieve this by combining biology and technology to create living organisms with new capabilities.

One of the key areas of focus for DNA is the production of high-value chemicals and materials. Traditional methods of manufacturing these products often rely on non-renewable resources and result in harmful byproducts. DNA, on the other hand, uses its expertise in genetic engineering to develop organisms that can produce these materials more sustainably and efficiently. By harnessing the power of biology, DNA is able to create processes that are not only more environmentally friendly but also more cost-effective.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Jason Kelly
Headquarters: Boston
Employees: 1292
Exchange: NYSE

add Ginkgo Bioworks Holdings to watchlist

Keep an eye on Ginkgo Bioworks Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Ginkgo Bioworks Holdings's (DNA) price per share?

The current price per share for Ginkgo Bioworks Holdings (DNA) is $7.31. The stock has seen a price change of -$1.29 recently, indicating a -15% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Ginkgo Bioworks Holdings (DNA)?

For Ginkgo Bioworks Holdings (DNA), the 52-week high is $75.2, which is 928.73% from the current price. The 52-week low is $5.26, the current price is 38.97% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Ginkgo Bioworks Holdings (DNA) a growth stock?

Ginkgo Bioworks Holdings (DNA) has shown an average price growth of -3.55% over the past three years. It has received a score of 94 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Ginkgo Bioworks Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Ginkgo Bioworks Holdings (DNA) stock price performance year to date (YTD)?

As of the latest data, Ginkgo Bioworks Holdings (DNA) has a year-to-date price change of -89.06%. Over the past month, the stock has experienced a price change of 0.41%. Over the last three months, the change has been -34.94%. Over the past six months, the figure is -78.26%.

help

Is Ginkgo Bioworks Holdings (DNA) a profitable company?

Ginkgo Bioworks Holdings (DNA) has a net income of -$892.87M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 56.73% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -274.48% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $251.46M, although specific revenue growth data is currently not available. The gross profit is $142.64M. Operating income is noted at -$672.23M. Furthermore, the EBITDA is -$633.69M.

help

What is the market capitalization of Ginkgo Bioworks Holdings (DNA)?

Ginkgo Bioworks Holdings (DNA) has a market capitalization of $406.26M. The average daily trading volume is 7.61, indicating the stock's liquidity and investor engagement.

News

Transforming Healthcare From The Inside Out, Nanorobots Are Revolutionizing Treatment With Precision At The Nanoscale: A Report by TNR, The Niche Research

NANOBOTS

HEALTHCARE

NANOROBOTS

TARGETED DRUG DELIVERY

MINIMALLY INVASIVE SURGERIES

Oct 2, 2024

Nanobots in Healthcare Research Report 2024: A $7.1 Billion Market in 2023 - Global Forecast to 2030 - Revolutionizing Healthcare with Targeted Drug Delivery and Minimally Invasive Surgeries

GINKGO BIOWORKS HOLDINGS, INC.

CLASS ACTION SETTLEMENT

SECURITIES FRAUD

Sep 18, 2024

Pomerantz LLP Announces that this is a Reminder of a Proposed Class Action Settlement on Behalf of Purchasers of Ginkgo Bioworks Holdings, Inc. Common Stock - DNA

GINKGO BIOWORKS

PROTEIN LANGUAGE MODEL

GOOGLE CLOUD CONSULTING

Sep 17, 2024

Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today

GOOGLE CLOUD

GINKGO BIOWORKS

DRUG DEVELOPMENT

PROTEIN LANGUAGE MODEL

MODEL API

Sep 17, 2024

Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development